Archangels - Making The Future


Companies seeking investment from Archangels should contact our Investment Executive team to outline their business proposal and investment needs.  Assuming that the basic Investment Criteria are met, then a business plan should be submitted to Archangels for review. This should include an overview of the company together with a brief financial summary outlining how much funding is being sought and how it will be used.

The Decision Process as to whether or not the syndicate wishes to progress an investment is designed to be as quick and helpful as possible.  However, companies should be aware that Archangels will review over 100 proposals in any one year and will probably invest in around 2-3 (a normal investment profile).

Our Investment Philosophy reflects a patient approach to building good companies on solid foundations.  We provide significant business experience as well as money and will continue to support good companies with follow-on rounds where appropriate.  We have experience and skills at achieving sensible exits at the right time for both founders and investors.

Latest News

Powerphotonic - Beam Shaper Optics for Industrial Materials Processing

01 Oct 2014
PowerPhotonic continues to expand its range of beam shaper micro-optics for industrial materials processing. There are options for all laser types including single mode and multi-mode lasers. Designed in UV-fused silica glass, they are ideal for multi kilowatt high power applications. Greater than 95% intensity uniformity can easily be achieved

Airborne Energy in action

20 Sep 2014
Airborne Energy's vertical axis turbines have now been installed on several test sites. Click on the link below to view one in action.

Cable gets to grips with Great British design

25 Jun 2014
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.

MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer

23 Jun 2014
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.

Touch Bionics founder receives Queen’s Honour

16 Jun 2014
David Gow named Commander of the Order of the British Empire Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.